Citi Resumes Johnson & Johnson (JNJ) at Buy, 'Streamlined '

May 30, 2023 4:01 AM EDT Send to a Friend
Citi analyst Joanna Wuensch resumes coverage on Johnson & Johnson (NYSE: JNJ) with a Buy rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login